[ad_1] European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating…
Tag: Biotechnology
Pfizer moves forward with once-daily version of weight loss pill after setbacks
[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward…
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
[ad_1] A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain,…
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
[ad_1] A sign with the company logo sits outside of the headquarters campus of Eli Lilly…
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter —…
Walgreens stock plunges as drugstore chain slashes profit guidance in ‘challenging’ consumer environment
[ad_1] In an aerial view, a customer enters a Walgreens store on January 04, 2024 in…
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
[ad_1] Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on…
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
[ad_1] Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for…
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
[ad_1] Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug…
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
[ad_1] A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at…
Here are 9 stocks that can benefit from Fed interest rate cuts
[ad_1] The S & P 500 and Nasdaq extended their record rallies this week following cooler-than-expected…
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
[ad_1] Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was…
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
[ad_1] A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters…